Professional Documents
Culture Documents
Radiationproctitis 090421073253 Phpapp02
Radiationproctitis 090421073253 Phpapp02
Dr Darren Tonkin
Colorectal Registrar
Contents
Acute radiation proctitis
Chronic radiation proctitis
Pathology
Investigation
Management
Conclusions
Acute Radiation Proctitis (ARP)
~75% of pts treated with pelvic XRT
Occurs during treatment and for several
weeks after completion
Symptoms usually mild and self limiting
Symptomatic treatment only
Clinical Manifestations - ARP
Diarrhoea (predominant)
Mucous discharge
Tenesmus
Abdominal & anal pain
Rectal bleeding (uncommon)
Chronic Radiation Proctitis (CRP)
2 to 20% of patients
Months to yrs following XRT
(median 8 - 13 months)
Significant negative effect on quality of
life
Natural history poorly understood
Clinical Manifestations - CRP
Bleeding (70%) Fistulae
Mucous discharge Stricture
Diarrhoea Obstruction
Pain Perforation
Urgency
Tenesmus
Incontinence
Pathology
Mucosal ulceration
Eosinophilic crypt abscesses
Obliterative endarteritis
Submucosal fibrosis
Neovascularization (telangiectasia)
Influencing Factors - CRP
Radiotherapy regimen
Radiation dose (>50Gy)
No. fields
Shielding
Delivery method (intracavity > EBRT)
Radiosensitizers, chemotherapy
Patient Factors
Diabetes
Previous abdominal surgery
Hypertension
Age
Investigation (1)
Flexible sigmoidoscopy, colonoscopy ± Bx
Limited data
Expensive
Time-consuming (20 - 40 treatments required)
Management - Endoscopic (1)
Topical Formalin
Adapted from use in radiation cystitis
4% formalin solution applied
Minimal relapse
GA often required
Refractory bleeding
Wound dehiscence
Pelvic sepsis
Management – Surgery (2)
Excision - preferred approach
Anterior resection + reconstruction
APR – perineal wound breakdown in 45%
Diversion
Prior to definitive surgery for strictures or
fistulae
Not indicated for bleeding
Conclusions
Medical management of little benefit
Topical formalin or Argon plasma
coagulation most effective
Surgery as last resort in complicated
cases
Poorly investigated in the past
Prospective, randomized trials required